New Age Alpha Advisors LLC Cuts Stake in HCA Healthcare, Inc. $HCA

New Age Alpha Advisors LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 90.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 748 shares of the company’s stock after selling 7,351 shares during the period. New Age Alpha Advisors LLC’s holdings in HCA Healthcare were worth $349,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare in the 4th quarter worth about $1,021,000. NewEdge Advisors LLC boosted its holdings in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC grew its stake in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares in the last quarter. Jump Financial LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. grew its stake in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE:HCA opened at $384.01 on Friday. The stock has a market capitalization of $85.19 billion, a P/E ratio of 13.21, a PEG ratio of 1.24 and a beta of 1.18. The company has a 50 day moving average price of $454.43 and a 200 day moving average price of $481.46. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Leerink Partners dropped their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. TD Cowen dropped their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Truist Financial decreased their price objective on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.